Tirzepatide offers more favorable return on investment, but greater benefits seen at lower costs for Roux-en-Y gastric bypass ...

Compared with usual care, GLP-1 receptor agonists tirzepatide and semaglutide may be cost-effective options for patients with ...

Compared with usual care, the glucagon-like peptide 1 receptor agonists (GLP-1 RAs) tirzepatide and semaglutide are cost-effective for people with knee osteoarthritis (OA) and obesity, according to a ...

Novo Nordisk , looking to turn around slowing growth of its blockbuster weight-loss drug Wegovy, plans to test whether its ...

Now, a team of researchers from the University of Utah, NYU, and Stanford University has discovered a new option: gait ...

A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for ...

Another round of free surgical mission is set to be held in Ilocos Norte next month. Ilocos Norte Governor Cecilia Araneta-Marcos confirmed this on Tuesday, as she encouraged interested residents to ...

A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs), semaglutide and tirzepatide, for patients with osteoarthritis and ...

GLP-1 RA tirzepatide may be more cost-effective for patients with obesity and knee osteoarthritis than semaglutide.

Tirzepatide is more cost-effective than semaglutide for knee osteoarthritis and obesity, optimizing resources for patients ...

In this microsimulation model, the two glucagon-like peptide-1 receptor agonists were shown to be cost-effective when added ...

A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs ...